- Home
- CLSD vs TNYA Comparison
CLSD vs TNYA Comparison
Compare CLSD & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSD
- TNYA
- Stock Information
- Founded
- CLSD 2011
- TNYA 2016
- Country
- CLSD United States
- TNYA United States
- Employees
- CLSD N/A
- TNYA N/A
- Industry
- CLSD Biotechnology: Pharmaceutical Preparations
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- CLSD Health Care
- TNYA Health Care
- Exchange
- CLSD Nasdaq
- TNYA Nasdaq
- Market Cap
- CLSD 69.0M
- TNYA 74.5M
- IPO Year
- CLSD 2016
- TNYA 2021
- Fundamental
- Price
- CLSD $0.76
- TNYA $0.46
- Analyst Decision
- CLSD Strong Buy
- TNYA Strong Buy
- Analyst Count
- CLSD 5
- TNYA 6
- Target Price
- CLSD $4.80
- TNYA $8.60
- AVG Volume (30 Days)
- CLSD 161.6K
- TNYA 2.3M
- Earning Date
- CLSD 05-14-2025
- TNYA 05-07-2025
- Dividend Yield
- CLSD N/A
- TNYA N/A
- EPS Growth
- CLSD N/A
- TNYA N/A
- EPS
- CLSD N/A
- TNYA N/A
- Revenue
- CLSD $3,764,000.00
- TNYA N/A
- Revenue This Year
- CLSD N/A
- TNYA N/A
- Revenue Next Year
- CLSD $476.77
- TNYA N/A
- P/E Ratio
- CLSD N/A
- TNYA N/A
- Revenue Growth
- CLSD N/A
- TNYA N/A
- 52 Week Low
- CLSD $0.70
- TNYA $0.36
- 52 Week High
- CLSD $1.65
- TNYA $4.29
- Technical
- Relative Strength Index (RSI)
- CLSD 34.26
- TNYA 48.93
- Support Level
- CLSD $0.77
- TNYA $0.43
- Resistance Level
- CLSD $0.91
- TNYA $0.46
- Average True Range (ATR)
- CLSD 0.06
- TNYA 0.04
- MACD
- CLSD -0.01
- TNYA 0.01
- Stochastic Oscillator
- CLSD 5.82
- TNYA 71.43
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.